Evidence supporting the use of: Lactobacillus reuteri
For the health condition: Enteritis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Lactobacillus reuteri is a probiotic bacterium that has been investigated for its potential to support or treat enteritis, which is inflammation of the intestine typically due to infection. Scientific studies, particularly randomized controlled trials and animal studies, provide moderate evidence supporting the use of L. reuteri in managing certain types of enteritis, especially those caused by infectious agents in children and animals.

Multiple clinical trials have demonstrated that L. reuteri supplementation can reduce the duration and severity of acute infectious diarrhea in children, a common manifestation of enteritis. For example, studies published in journals such as Pediatrics and The Journal of Pediatric Gastroenterology and Nutrition have shown that L. reuteri DSM 17938 can decrease stool frequency and hasten recovery in cases of rotavirus and other viral/bacterial enteritis.

The proposed mechanisms include competitive inhibition of pathogenic bacteria, enhancement of intestinal barrier function, and modulation of the host immune response. Moreover, animal studies indicate that L. reuteri may reduce inflammatory markers and protect the gut mucosa during experimentally induced enteritis.

However, while evidence is promising, it is not yet conclusive for all populations or all causes of enteritis. Most robust data are in pediatric acute infectious diarrhea, with less strong evidence for chronic enteritis or adult populations. In summary, the use of L. reuteri for enteritis is scientifically justified with moderate strength of evidence, particularly in pediatric settings.

More about lactobacillus reuteri
More about Enteritis